Aiforia expands its global reach through a partnership with Quorum Technologies in Canada

Aiforia Technologies Plc, Press Release, March 18, 2025 at 09:00 a.m. EET

Aiforia Technologies, a pioneer in AI-powered image analysis in pathology, today announced a partnership with Quorum Technologies. This collaboration seeks to accelerate the adoption of Aiforia’s AI-assisted image analysis solutions across Canada. By combining their collective expertise, the companies aim to enhance scientific discoveries and patient care through improved accuracy and increased workflow efficiency in digital pathology image analysis.

“The digital pathology market is gaining increasing traction in Canada, and laboratories are seeking AI solutions to streamline and enhance pathologist’s workflows. Through this partnership, we will make our AI solutions more accessible to the Canadian healthcare sector, addressing the needs of both researchers and pathologists. We are excited to collaborate with a strong Canadian healthcare solution provider, Quorum Technologies, who can support our entry to the Canadian market,” says Jukka Tapaninen, CEO of Aiforia.

“Quorum has long supported the evolution of digital pathology in Canada, and partnering with Aiforia is a natural extension of our commitment to providing innovative solutions for pathologists and researchers. Our expertise in workflow integration, combined with Aiforia’s AI-driven image analysis, empowers laboratories to optimize efficiency, enhance diagnostic accuracy, and improve patient outcomes,” says John Arbuckle, President and founder of Quorum Technologies.

Further inquiries: 
Jukka Tapaninen, CEO, Aiforia Technologies Plc
tel. +33 61 041 6686
https://investors.aiforia.com/

Certified Adviser 
UB Corporate Finance Ltd
ubcf@unitedbankers.fi

About Aiforia

Aiforia is a trusted provider of deep learning artificial intelligence (AI) solutions for pathology. Aiforia delivers software solutions that elevate diagnostic capabilities in image analysis, enabling remarkable medical discoveries now and in the future. With thousands of AI models already developed on the Aiforia platform for research use and several diagnostic solutions deployed, Aiforia is already significantly impacting pathology and healthcare.

Founded in 2013, Aiforia is a publicly traded company operating internationally with thousands of platform users across the globe. The company is headquartered in Helsinki, Finland, with offices in Cambridge, Massachusetts, and Rochester, Minnesota, and local representatives across Europe and North America. The diverse team at Aiforia includes experienced pathologists, medical scientists, AI and software developers, and a dedicated commercial team. Together, they are working to transform pathology with AI, enabling better care for each patient. Find out more at www.aiforia.com

About Quorum Technologies

Quorum Technologies Inc. is a private, Canadian-owned enterprise located in Puslinch, Ontario. The company develops and integrates scientific instruments and is the largest independent provider of microscope-based imaging systems in Canada. Quorum is a leader in advanced Live Cell Imaging platforms and Digital Pathology solutions and has over 30 years of experience integrating microscope components to meet the goals of the scientific community. Through its technology transfer relationships with Canadian universities, Quorum is helping to bring new innovative technologies to market for preclinical research, drug development and personalized medicine. Find out more at www.quorumtechnologies.com